InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the full record of transactions filed by Humphrey Rachel, Director. Director active across 1 company, notably Pyxis Oncology, Inc.. Cumulatively, 3 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €1k. Activity tracked since 24 March 2023. The latest transaction was disclosed on 14 April 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Humphrey Rachel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
1,400 shares@ US$0.97270.0008% mcap50.0% of flowCommon StockSEC:0000905148-26-001434:0
38,741 shares0Common StockSEC:0000950170-24-038099:0
58,064 shares0Common StockSEC:0001209191-23-021408:0
3 of 3 declarations
About Humphrey Rachel
Humphrey Rachel is a Director at Pyxis Oncology, Inc. She plays a key role in the governance of the company, contributing to strategic decisions and overseeing operations. Her experience in the biotechnology sector is valuable for the company's development.
